Related Experiment Video
Updated: Jul 2, 2026

Closure of a Patent Foramen Ovale (PFO): An Intervention Sequence
Published on: December 23, 2022
Novel TFAP2B mutation in nonsyndromic patent ductus arteriosus
Maher Khetyar1, Petros Syrris, Lorna Tinworth
1Division of Clinical Developmental Sciences, St. George's University of London, London, United Kingdom. mkhetyar@sgul.ac.uk
Abstract:
Mutations in the gene encoding the TFAP2B transcription factor can cause Char syndrome with cardiac, craniofacial, and hand abnormalities. However, TFAP2B mutations result in great phenotypic variability, which is believed to reflect different expression patterns of tissue-specific TFAP2 coactivators. We investigated a consanguineous family with isolated patent ductus arteriosus (PDA) for mutations in TFAP2B. Our study suggests that a novel splicing mutation in TFAP2B can cause isolated PDA without other clinical features.
Related Concept Videos
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests

